OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 52.17 Million USD | -35.65% |
| 2022 | 81.08 Million USD | 0.78% |
| 2021 | 80.45 Million USD | 43.93% |
| 2020 | 55.9 Million USD | 32.62% |
| 2019 | 42.15 Million USD | 30.93% |
| 2018 | 32.19 Million USD | -15.55% |
| 2017 | 38.12 Million USD | 72.61% |
| 2016 | 22.08 Million USD | -26.1% |
| 2015 | 29.88 Million USD | -3.38% |
| 2014 | 30.93 Million USD | 33.91% |
| 2013 | 23.09 Million USD | 7.89% |
| 2012 | 21.41 Million USD | -22.46% |
| 2011 | 27.61 Million USD | 40.33% |
| 2010 | 19.67 Million USD | -15.13% |
| 2009 | 23.18 Million USD | -1.73% |
| 2008 | 23.59 Million USD | -13.57% |
| 2007 | 27.29 Million USD | 0.87% |
| 2006 | 27.06 Million USD | 128.79% |
| 2005 | 11.82 Million USD | -5.28% |
| 2004 | 12.48 Million USD | -1.22% |
| 2003 | 12.64 Million USD | 30.08% |
| 2002 | 9.71 Million USD | -9.55% |
| 2001 | 10.74 Million USD | -7.09% |
| 2000 | 11.56 Million USD | 450.67% |
| 1999 | 2.1 Million USD | 0.0% |
| 1998 | 2.1 Million USD | 5.0% |
| 1997 | 2 Million USD | -87.73% |
| 1996 | 16.3 Million USD | 108.97% |
| 1995 | 7.8 Million USD | 27.87% |
| 1994 | 6.1 Million USD | 0.0% |
| 1993 | 6.1 Million USD | -6.15% |
| 1992 | 6.5 Million USD | 622.22% |
| 1991 | 900 Thousand USD | 28.57% |
| 1990 | 700 Thousand USD | -22.22% |
| 1989 | 900 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 40.5 Million USD | -1.95% |
| 2024 Q1 | 41.3 Million USD | -20.83% |
| 2023 Q2 | 59.45 Million USD | -8.86% |
| 2023 Q3 | 16.79 Million USD | -71.76% |
| 2023 Q4 | 52.17 Million USD | 210.74% |
| 2023 FY | 52.17 Million USD | -35.65% |
| 2023 Q1 | 65.23 Million USD | -19.55% |
| 2022 Q2 | 85.06 Million USD | 20.41% |
| 2022 Q3 | 90.31 Million USD | 6.18% |
| 2022 Q4 | 81.08 Million USD | -10.22% |
| 2022 Q1 | 70.64 Million USD | -12.19% |
| 2022 FY | 81.08 Million USD | 0.78% |
| 2021 FY | 80.45 Million USD | 43.93% |
| 2021 Q4 | 80.45 Million USD | 18.43% |
| 2021 Q3 | 67.93 Million USD | 12.79% |
| 2021 Q2 | 60.23 Million USD | 13.75% |
| 2021 Q1 | 52.95 Million USD | -5.28% |
| 2020 Q3 | 48.51 Million USD | 24.18% |
| 2020 Q2 | 39.07 Million USD | 11.88% |
| 2020 Q1 | 34.92 Million USD | -17.15% |
| 2020 FY | 55.9 Million USD | 32.62% |
| 2020 Q4 | 55.9 Million USD | 15.22% |
| 2019 FY | 42.15 Million USD | 30.93% |
| 2019 Q3 | 37.85 Million USD | -3.54% |
| 2019 Q4 | 42.15 Million USD | 11.34% |
| 2019 Q1 | 38.41 Million USD | 19.34% |
| 2019 Q2 | 39.24 Million USD | 2.15% |
| 2018 Q1 | 27.2 Million USD | -28.63% |
| 2018 FY | 32.19 Million USD | -15.55% |
| 2018 Q4 | 32.19 Million USD | 16.84% |
| 2018 Q3 | 27.55 Million USD | 1.33% |
| 2018 Q2 | 27.19 Million USD | -0.05% |
| 2017 FY | 38.12 Million USD | 72.61% |
| 2017 Q3 | 32.74 Million USD | 13.15% |
| 2017 Q1 | 23.76 Million USD | 7.62% |
| 2017 Q4 | 38.12 Million USD | 16.41% |
| 2017 Q2 | 28.93 Million USD | 21.76% |
| 2016 Q2 | 31.13 Million USD | 22.26% |
| 2016 Q4 | 22.08 Million USD | -18.43% |
| 2016 Q1 | 25.46 Million USD | -14.79% |
| 2016 FY | 22.08 Million USD | -26.1% |
| 2016 Q3 | 27.07 Million USD | -13.03% |
| 2015 Q3 | 33.84 Million USD | 67.35% |
| 2015 Q1 | 21.81 Million USD | -29.47% |
| 2015 Q2 | 20.22 Million USD | -7.29% |
| 2015 FY | 29.88 Million USD | -3.38% |
| 2015 Q4 | 29.88 Million USD | -11.71% |
| 2014 FY | 30.93 Million USD | 33.91% |
| 2014 Q2 | 19.24 Million USD | -0.62% |
| 2014 Q3 | 29.57 Million USD | 53.68% |
| 2014 Q4 | 30.93 Million USD | 4.58% |
| 2014 Q1 | 19.36 Million USD | -16.16% |
| 2013 Q2 | 19.87 Million USD | -10.16% |
| 2013 Q3 | 23.32 Million USD | 17.36% |
| 2013 Q4 | 23.09 Million USD | -0.95% |
| 2013 FY | 23.09 Million USD | 7.89% |
| 2013 Q1 | 22.11 Million USD | 3.31% |
| 2012 Q4 | 21.41 Million USD | -1.66% |
| 2012 Q2 | 25.89 Million USD | 6.18% |
| 2012 Q3 | 21.77 Million USD | -15.91% |
| 2012 Q1 | 24.38 Million USD | -11.69% |
| 2012 FY | 21.41 Million USD | -22.46% |
| 2011 FY | 27.61 Million USD | 40.33% |
| 2011 Q3 | 26.83 Million USD | 33.8% |
| 2011 Q4 | 27.61 Million USD | 2.9% |
| 2011 Q1 | 18.22 Million USD | -7.4% |
| 2011 Q2 | 20.05 Million USD | 10.06% |
| 2010 Q1 | 19.24 Million USD | -16.98% |
| 2010 FY | 19.67 Million USD | -15.13% |
| 2010 Q4 | 19.67 Million USD | 6.96% |
| 2010 Q3 | 18.39 Million USD | -15.78% |
| 2010 Q2 | 21.84 Million USD | 13.5% |
| 2009 Q3 | 21.86 Million USD | 15.73% |
| 2009 Q1 | 19.47 Million USD | -17.47% |
| 2009 FY | 23.18 Million USD | -1.73% |
| 2009 Q4 | 23.18 Million USD | 6.02% |
| 2009 Q2 | 18.89 Million USD | -2.97% |
| 2008 Q1 | 21.44 Million USD | -21.46% |
| 2008 FY | 23.59 Million USD | -13.57% |
| 2008 Q2 | 22.44 Million USD | 4.68% |
| 2008 Q3 | 20.77 Million USD | -7.46% |
| 2008 Q4 | 23.59 Million USD | 13.58% |
| 2007 Q4 | 27.29 Million USD | 12.73% |
| 2007 FY | 27.29 Million USD | 0.87% |
| 2007 Q2 | 24.7 Million USD | 2.82% |
| 2007 Q1 | 24.02 Million USD | -11.21% |
| 2007 Q3 | 24.21 Million USD | -1.97% |
| 2006 FY | 27.06 Million USD | 128.79% |
| 2006 Q3 | 22.35 Million USD | 2.46% |
| 2006 Q1 | 9.87 Million USD | -16.51% |
| 2006 Q2 | 21.82 Million USD | 120.96% |
| 2006 Q4 | 27.06 Million USD | 21.03% |
| 2005 Q1 | 11.61 Million USD | -6.96% |
| 2005 FY | 11.82 Million USD | -5.28% |
| 2005 Q4 | 11.82 Million USD | -5.73% |
| 2005 Q3 | 12.54 Million USD | 4.94% |
| 2005 Q2 | 11.95 Million USD | 2.92% |
| 2004 FY | 12.48 Million USD | -1.22% |
| 2004 Q1 | 11.68 Million USD | -7.57% |
| 2004 Q3 | 11.55 Million USD | -9.65% |
| 2004 Q4 | 12.48 Million USD | 8.04% |
| 2004 Q2 | 12.79 Million USD | 9.49% |
| 2003 Q1 | 10.1 Million USD | 4.0% |
| 2003 Q3 | 10.92 Million USD | 3.24% |
| 2003 FY | 12.64 Million USD | 30.08% |
| 2003 Q2 | 10.57 Million USD | 4.68% |
| 2003 Q4 | 12.64 Million USD | 15.75% |
| 2002 Q3 | 9.71 Million USD | 3.66% |
| 2002 Q4 | 9.71 Million USD | 0.07% |
| 2002 Q1 | 9.44 Million USD | -12.12% |
| 2002 Q2 | 9.36 Million USD | -0.77% |
| 2002 FY | 9.71 Million USD | -9.55% |
| 2001 Q1 | 10.15 Million USD | -12.22% |
| 2001 Q2 | 10.84 Million USD | 6.83% |
| 2001 Q3 | 10.46 Million USD | -3.52% |
| 2001 Q4 | 10.74 Million USD | 2.68% |
| 2001 FY | 10.74 Million USD | -7.09% |
| 2000 Q2 | 1.85 Million USD | 25.39% |
| 2000 FY | 11.56 Million USD | 450.67% |
| 2000 Q4 | 11.56 Million USD | -21.17% |
| 2000 Q1 | 1.48 Million USD | -19.83% |
| 2000 Q3 | 14.67 Million USD | 690.02% |
| 1999 Q1 | 1.6 Million USD | -11.11% |
| 1999 Q3 | 2.1 Million USD | 23.53% |
| 1999 Q4 | 1.84 Million USD | -12.04% |
| 1999 Q2 | 1.7 Million USD | 6.25% |
| 1999 FY | 2.1 Million USD | 0.0% |
| 1998 Q2 | 1.9 Million USD | 0.0% |
| 1998 Q4 | 1.8 Million USD | -14.29% |
| 1998 FY | 2.1 Million USD | 5.0% |
| 1998 Q1 | 1.9 Million USD | -29.63% |
| 1998 Q3 | 2.1 Million USD | 10.53% |
| 1997 Q3 | 2 Million USD | -51.22% |
| 1997 FY | 2 Million USD | -87.73% |
| 1997 Q1 | 4.7 Million USD | -60.17% |
| 1997 Q2 | 4.1 Million USD | -12.77% |
| 1997 Q4 | 2.7 Million USD | 35.0% |
| 1996 Q4 | 11.8 Million USD | -27.61% |
| 1996 Q1 | 6.9 Million USD | 1.47% |
| 1996 Q2 | 5.6 Million USD | -18.84% |
| 1996 Q3 | 16.3 Million USD | 191.07% |
| 1996 FY | 16.3 Million USD | 108.97% |
| 1995 Q1 | 5.6 Million USD | -13.85% |
| 1995 Q2 | 6.5 Million USD | 16.07% |
| 1995 Q3 | 7.8 Million USD | 20.0% |
| 1995 Q4 | 6.8 Million USD | -12.82% |
| 1995 FY | 7.8 Million USD | 27.87% |
| 1994 FY | 6.1 Million USD | 0.0% |
| 1994 Q4 | 6.5 Million USD | 6.56% |
| 1994 Q3 | 6.1 Million USD | 5.17% |
| 1994 Q2 | 5.8 Million USD | -4.92% |
| 1994 Q1 | 6.1 Million USD | 7.02% |
| 1993 FY | 6.1 Million USD | -6.15% |
| 1993 Q1 | 5.8 Million USD | -14.71% |
| 1993 Q2 | 5.9 Million USD | 1.72% |
| 1993 Q3 | 6.1 Million USD | 3.39% |
| 1993 Q4 | 5.7 Million USD | -6.56% |
| 1992 Q2 | 6.9 Million USD | 1280.0% |
| 1992 Q1 | 500 Thousand USD | 0.0% |
| 1992 FY | 6.5 Million USD | 622.22% |
| 1992 Q3 | 6.5 Million USD | -5.8% |
| 1992 Q4 | 6.8 Million USD | 4.62% |
| 1991 Q3 | 900 Thousand USD | 80.0% |
| 1991 Q2 | 500 Thousand USD | -44.44% |
| 1991 Q1 | 900 Thousand USD | 28.57% |
| 1991 FY | 900 Thousand USD | 28.57% |
| 1991 Q4 | 500 Thousand USD | -44.44% |
| 1990 Q2 | 900 Thousand USD | 80.0% |
| 1990 FY | 700 Thousand USD | -22.22% |
| 1990 Q3 | 700 Thousand USD | -22.22% |
| 1990 Q1 | 500 Thousand USD | 0.0% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1989 FY | 900 Thousand USD | 0.0% |
| 1989 Q4 | 500 Thousand USD | -44.44% |
| 1989 Q2 | 600 Thousand USD | 0.0% |
| 1989 Q3 | 900 Thousand USD | 50.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 58.788% |
| AngioDynamics, Inc. | 112.08 Million USD | 53.451% |
| AtriCure, Inc. | 147.76 Million USD | 64.691% |
| Avinger, Inc. | 19.97 Million USD | -161.236% |
| Azenta, Inc. | 351.22 Million USD | 85.145% |
| BioLife Solutions, Inc. | 75.05 Million USD | 30.482% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 98.73% |
| Daxor Corporation | 858.75 Thousand USD | -5975.518% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -219.85% |
| Femasys Inc. | 9.4 Million USD | -454.852% |
| GlucoTrack, Inc. | 1.7 Million USD | -2954.684% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 18.848% |
| Hologic, Inc. | 4.02 Billion USD | 98.704% |
| ICU Medical, Inc. | 2.25 Billion USD | 97.686% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 97.448% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -543.551% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -6.743% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -7805.918% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -7805.918% |
| Masimo Corporation | 1.67 Billion USD | 96.888% |
| Microbot Medical Inc. | 3.82 Million USD | -1263.67% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -108.051% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 95.355% |
| Nephros, Inc. | 3.5 Million USD | -1389.409% |
| NovoCure Limited | 783.63 Million USD | 93.342% |
| NEXGEL, Inc. | 4.78 Million USD | -989.455% |
| NEXGEL, Inc. | 4.78 Million USD | -989.455% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 39.656% |
| Pro-Dex, Inc. | 23.34 Million USD | -123.51% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -217.283% |
| Predictive Oncology Inc. | 6.14 Million USD | -748.983% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -662.244% |
| QuidelOrtho Corporation | 3.55 Billion USD | 98.533% |
| Repligen Corporation | 853.2 Million USD | 93.885% |
| Sanara MedTech Inc. | 29.28 Million USD | -78.171% |
| STAAR Surgical Company | 102.73 Million USD | 49.216% |
| Sharps Technology, Inc. | 3.85 Million USD | -1253.417% |
| Utah Medical Products, Inc. | 7.14 Million USD | -630.217% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 98.72% |
| Jin Medical International Ltd. | 8.92 Million USD | -484.626% |